INTELLIPHARMACEUTICS INTERNATIONAL INC. Total Assets
INTELLIPHARMACEUTICS INTERNATIONAL INC. had Total Assets of $1.57 million as of 2023-08-31, per its 6-K filed 2023-10-16.
Discontinued › Balance Sheet › Assets
us-gaap:Assets · last filed 2024-02-06
- 2018-11-30: Assets 11.47M CAD.
- 2017-11-30: Assets 7.40M CAD.
- 2017-05-31: Assets 7.78M CAD.
- 2017-02-28: Assets 7.96M CAD.
CAD
| Period end | Assets |
|---|---|
| 2018-11-30 | 11.47M CAD 20-F · filed 2019-03-04 |
| 2017-11-30 | 7.40M CAD 20-F · filed 2019-03-04 |
| 2017-05-31 | 7.78M CAD 6-K · filed 2017-07-11 |
| 2017-02-28 | 7.96M CAD 6-K · filed 2017-04-12 |
| 2016-11-30 | 7.97M CAD 20-F · filed 2018-03-01 |
| 2015-11-30 | 5.22M CAD 20-F · filed 2017-02-28 |
USD
| Period end | Assets |
|---|---|
| 2023-08-31 | $1.57M 6-K · filed 2023-10-16 |
| 2023-05-31 | $1.74M 6-K · filed 2023-09-26 |
| 2023-02-28 | $1.60M 6-K · filed 2023-09-26 |
| 2022-11-30 | $1.43M 20-F/A · filed 2024-02-06 |
| 2022-08-31 | $1.44M 6-K · filed 2022-10-14 |
| 2022-05-31 | $1.88M 6-K · filed 2022-07-21 |
| 2022-02-28 | $1.89M 6-K · filed 2022-07-21 |
| 2021-11-30 | $2.10M 20-F/A · filed 2024-02-06 |
| 2021-08-31 | $3.46M 6-K · filed 2021-10-15 |
| 2021-05-31 | $4.98M 6-K · filed 2021-07-15 |
| 2021-02-28 | $2.68M 6-K · filed 2021-04-14 |
| 2020-11-30 | $3.39M 20-F/A · filed 2022-05-09 |
| 2020-08-31 | $4.22M 6-K · filed 2020-10-15 |
| 2020-05-31 | $3.56M 6-K · filed 2020-07-15 |
| 2020-02-29 | $3.60M 6-K · filed 2020-05-29 |
| 2019-11-30 | $3.80M 20-F · filed 2021-03-31 |
| 2019-08-31 | $4.16M 6-K · filed 2019-10-11 |
| 2019-05-31 | $5.57M 6-K · filed 2019-07-10 |
| 2019-02-28 | $7.55M 6-K · filed 2019-04-15 |
| 2018-11-30 | $11.47M 20-F · filed 2020-03-30 |
| 2018-08-31 | $5.63M 6-K · filed 2018-10-15 |
| 2018-05-31 | $6.67M 6-K · filed 2018-07-24 |
| 2017-11-30 | $7.40M 6-K · filed 2018-10-15 |
| 2015-11-30 | $5.22M 20-F · filed 2016-03-21 |
| 2014-11-30 | $7.88M 20-F · filed 2016-03-21 |
| 2014-02-28 | $10.45M 6-K · filed 2014-04-14 |
| 2013-11-30 | $4.38M 20-F · filed 2015-02-27 |
| 2012-11-30 | $2.47M 20-F · filed 2014-02-18 |
| 2011-11-30 | $6.25M 20-F/A · filed 2013-02-01 |
| 2010-11-30 | $3.27M 20-F/A · filed 2013-02-01 |